QUOTED. March 1, 2018. Joerg Kruetten.
Check out what Simon-Kucher & Partners consultant Joerg Kruetten had to say about the opportunities and pitfalls of new medtech business models based on his firm's "Medtech Barometer" survey.
You may also be interested in...
European medtech companies are changing the way they do business. These new business models are enabling them to overcome market challenges and will allow them to keep growing their business if successfully implemented, an industry survey by Simon-Kucher & Partners has revealed.
Two top officials in the US FDA’s device center are warning of delays in the agency’s review of submissions for new products that aren’t directly tied to the coronavirus pandemic.
With 12 new BTDs announced so far this year, 2021 is on pace to match the COVID-19-depressed total number of designations in 2020. Here’s a breakdown of the candidates that have received the designation.